Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis

Research output: Contribution to journalReview article

Abstract

Exposures that carry risk of transmission of blood-borne disease are rare in pediatrics, but expose patients and families to great anxiety. Specialists in pediatric infectious diseases are often asked about initial antimicrobial prophylaxis in these cases. Guidelines for nonoccupational postexposure prophylaxis for human immunodeficiency virus have evolved as new formulations and medications become available and greater experience obtained in assessing relative risks of different exposures and relative costs and benefits for different interventions. This article discusses the evidence behind recent updates to Centers for Disease Control and Prevention guidelines for nonoccupational postexposure prophylaxis for human immunodeficiency virus, focusing on application in the pediatric population.

Original languageEnglish (US)
Pages (from-to)91-101
Number of pages11
JournalInfectious Disease Clinics of North America
Volume32
Issue number1
DOIs
StatePublished - Mar 1 2018

Fingerprint

HIV
Pediatrics
Guidelines
Hematologic Diseases
Centers for Disease Control and Prevention (U.S.)
Cost-Benefit Analysis
Communicable Diseases
Anxiety
Population

Keywords

  • Antivirals
  • Blood-borne infections
  • Human immunodeficiency virus
  • Needlestick
  • Postexposure prophylaxis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

@article{ad93721da0a74f128f5debabcf7a1b14,
title = "Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis",
abstract = "Exposures that carry risk of transmission of blood-borne disease are rare in pediatrics, but expose patients and families to great anxiety. Specialists in pediatric infectious diseases are often asked about initial antimicrobial prophylaxis in these cases. Guidelines for nonoccupational postexposure prophylaxis for human immunodeficiency virus have evolved as new formulations and medications become available and greater experience obtained in assessing relative risks of different exposures and relative costs and benefits for different interventions. This article discusses the evidence behind recent updates to Centers for Disease Control and Prevention guidelines for nonoccupational postexposure prophylaxis for human immunodeficiency virus, focusing on application in the pediatric population.",
keywords = "Antivirals, Blood-borne infections, Human immunodeficiency virus, Needlestick, Postexposure prophylaxis",
author = "Muller, {William J} and Ellen Chadwick",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.idc.2017.10.006",
language = "English (US)",
volume = "32",
pages = "91--101",
journal = "Infectious Disease Clinics of North America",
issn = "0891-5520",
publisher = "W.B. Saunders Ltd",
number = "1",

}

Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis. / Muller, William J; Chadwick, Ellen.

In: Infectious Disease Clinics of North America, Vol. 32, No. 1, 01.03.2018, p. 91-101.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis

AU - Muller, William J

AU - Chadwick, Ellen

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Exposures that carry risk of transmission of blood-borne disease are rare in pediatrics, but expose patients and families to great anxiety. Specialists in pediatric infectious diseases are often asked about initial antimicrobial prophylaxis in these cases. Guidelines for nonoccupational postexposure prophylaxis for human immunodeficiency virus have evolved as new formulations and medications become available and greater experience obtained in assessing relative risks of different exposures and relative costs and benefits for different interventions. This article discusses the evidence behind recent updates to Centers for Disease Control and Prevention guidelines for nonoccupational postexposure prophylaxis for human immunodeficiency virus, focusing on application in the pediatric population.

AB - Exposures that carry risk of transmission of blood-borne disease are rare in pediatrics, but expose patients and families to great anxiety. Specialists in pediatric infectious diseases are often asked about initial antimicrobial prophylaxis in these cases. Guidelines for nonoccupational postexposure prophylaxis for human immunodeficiency virus have evolved as new formulations and medications become available and greater experience obtained in assessing relative risks of different exposures and relative costs and benefits for different interventions. This article discusses the evidence behind recent updates to Centers for Disease Control and Prevention guidelines for nonoccupational postexposure prophylaxis for human immunodeficiency virus, focusing on application in the pediatric population.

KW - Antivirals

KW - Blood-borne infections

KW - Human immunodeficiency virus

KW - Needlestick

KW - Postexposure prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=85041342828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041342828&partnerID=8YFLogxK

U2 - 10.1016/j.idc.2017.10.006

DO - 10.1016/j.idc.2017.10.006

M3 - Review article

VL - 32

SP - 91

EP - 101

JO - Infectious Disease Clinics of North America

JF - Infectious Disease Clinics of North America

SN - 0891-5520

IS - 1

ER -